口服干扰素治疗慢性乙型肝炎的研究  

A STUDY ON ORAFERON THERAPY OF CHRONIC HEPATITIS B

作　　者：高燕[1] 冯百芳[1] 陶其敏[1] 孙炎[1] 

机构地区：[1]北京医科大学人民医院肝病研究所

出　　处：《北京医科大学学报》1993年第2期97-99,共3页Journal of Peking University(Health Sciences)

摘　　要：本文报道40例慢性乙型肝炎患者口服干扰素随机双盲对照治疗一年,结果表明肝功能改善治疗组为50％,对照组为10％;HBSAg滴度下降,eAg转阴同时伴eAb转阳治疗组为30％,对照组为10％。其机理及扩大临床应用有待进一步研究。This paper presents the study of a double-blind random trial on 40 cases using Oraferon for oneYear. The results showed that ALT and AST level recovered to normal in 50% of cases in thetreated group and 10% in the control group. HBsAg titer dropped and HBeAg reversed to anti-HBe in30% of the cases in the treated groups and 10% in the control group However, further study on themechanism of the action of oraferon and its wider clinical application are expected.

关 键 词：乙型肝炎 干扰素 谷草转氨酶 

分 类 号：R512.62[医药卫生—内科学]